Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Floyd Livingston

Pediatric Pulmonology Orlando, FL Medical Doctor

NPI 1164531927 CMS profile 324800

1717 S Orange Ave, Suite 100, Orlando, FL 32806

Open in the dashboard

General payments

$109,994

345 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$892,881 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Floyd Livingston of Orlando, FL is reported in the CMS Open Payments database as having received $109,994 across 345 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $892,881 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42,625 52
2024 General $12,866 25
2023 General $9,311 36
2022 General $12,809 44
2021 General $1,217 38
2020 General $5,806 36
2019 General $25,361 114

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Floyd Livingston
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Floyd Livingston were reported at $42,625. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Floyd Livingston Pediatric Pulmonology median Middle half National median
2019 $25,361 $151 $59–$495 $163
2020 $5,806 $107 $34–$339 $114
2021 $1,217 $125 $40–$511 $132
2022 $12,809 $133 $49–$428 $149
2023 $9,311 $138 $44–$494 $160
2024 $12,866 $132 $46–$398 $164
2025 $42,625 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sanofi Pasteur Inc. $69,592 56 payments
  2. Sobi, Inc $11,247 41 payments
  3. Vertex Pharmaceuticals Incorporated $7,255 28 payments
  4. Novartis Pharmaceuticals Corporation $4,561 26 payments
  5. Genentech USA, Inc. $4,249 16 payments
  6. Mylan Specialty L.P. $4,111 13 payments
  7. Merck Sharp & Dohme Corporation $2,960 2 payments
  8. Genzyme Corporation $1,089 23 payments
  9. Jazz Pharmaceuticals Inc. $1,032 23 payments
  10. AstraZeneca Pharmaceuticals LP $648 13 payments
  11. Other $3,252 104 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $76,753 20 payments
  2. Food and Beverage $11,592 278 payments
  3. Travel and Lodging $11,417 40 payments
  4. Consulting Fee $10,153 5 payments
  5. Education $80 2 payments
Products named General payments · program years 2019–2025
  1. BEYFORTUS $52,131 38 payments
  2. SYNAGIS $10,909 37 payments
  3. SYMDEKO $5,732 6 payments
  4. XOLAIR Respiratory $4,527 25 payments
  5. Xolair Immunology $4,160 11 payments
  6. TOBI $3,970 7 payments
  7. DUPIXENT Immunology $1,008 19 payments
  8. XYWAV $596 12 payments
  9. DUPIXENT Inflammation And Immunology $495 9 payments
  10. INSPIRE $317 5 payments
  11. Other $4,678 140 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

345 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record